Innoviz Technologies Ltd.·4

Jul 8, 8:00 PM ET

Keilaf Omer David 4

4 · Innoviz Technologies Ltd. · Filed Jul 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Innoviz (INVZ) CEO Keilaf Omer David Transfers Shares (Divorce)

What Happened
Keilaf Omer David, CEO of Innoviz Technologies Ltd. (INVZ), transferred 679,400 ordinary shares and derivative instruments representing the right to purchase an aggregate of 907,511 ordinary shares to his former spouse pursuant to a divorce settlement. All transfers were reported as dispositions at $0.00 per share (no cash consideration). The filing lists the transfers as occurring on July 7, 2026 and was filed with the SEC on July 9, 2026.

Key Details

  • Transaction date: July 7, 2026; Form 4 filed July 9, 2026 (appears timely under the two‑business‑day rule).
  • Disposed: 679,400 ordinary shares (direct shares) and derivative interests totaling 907,511 shares (reported as separate derivative dispositions). Total consideration reported: $0.
  • Footnotes: F1 confirms the transfers (shares + options) were to former spouse Ms. Gali Moscovici pursuant to a divorce settlement; F3 reiterates no consideration was paid.
  • Derivative and award details: Footnote F2 describes 916,552 RSUs issuable upon vesting (with detailed vesting schedules across 2022–2029); F5 and F6 describe option grants (Aug 9, 2022 and Aug 1, 2023) with vested and unvested balances and scheduled vesting; F4 notes certain option rights are immediately exercisable.
  • Shares owned after transaction: Not specified in the excerpt of the filing provided.

Context

  • Transfers incident to divorce are not purchases or sales motivated by market views; they are personal transfers and do not necessarily indicate insider sentiment about the company.
  • The filing includes transfers of both vested shares and derivative awards (options/RSUs). RSUs and unvested options have vesting schedules and, for many, vesting is contingent on continued service.
  • No cash changed hands (reported $0 consideration), so this is effectively a family/settlement transfer rather than a market sale.

Insider Transaction Report

Form 4
Period: 2026-07-07
Keilaf Omer David
DirectorChief Executive Officer
Transactions
  • Other

    Ordinary Shares

    [F1][F2][F3]
    2026-07-07679,4002,826,531 total
  • Other

    Share Option

    [F4][F1]
    2026-07-07510,222510,222 total
    Exercise: $11.50Exp: 2028-05-12Ordinary Shares (510,222 underlying)
  • Other

    Share Option

    [F4][F1]
    2026-07-07342,408342,408 total
    Exercise: $9.92Exp: 2028-05-12Ordinary Shares (342,408 underlying)
  • Other

    Share Option

    [F5][F1]
    2026-07-0729,24064,328 total
    Exercise: $5.23Exp: 2029-08-09Ordinary Shares (29,240 underlying)
  • Other

    Share Option

    [F6][F1]
    2026-07-0725,64191,575 total
    Exercise: $4.03Exp: 2030-08-01Ordinary Shares (25,641 underlying)
Footnotes (6)
  • [F1]Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.
  • [F2]The amount includes 916,552 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 7,798 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 62,978 RSUs granted February 27, 2024, with 10,674 vesting quarterly through 2027 and 52,304 vesting quarterly through 2028; (d) 54,531 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 75,251 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 562,500 RSUs granted May 26, 2025, vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
  • [F3]No consideration was paid in connection with the transfer. No exercise price is applicable.
  • [F4]Immediately exercisable.
  • [F5]Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
  • [F6]Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
Signature
/s/ Dafna Raz - Attorney-in-Fact|2026-07-09

Documents

1 file
  • 4
    zk2635665.xmlPrimary

    FORM 4